Figure 2 Interaction effects between heterozygous HLA‑DRB1

Slides:



Advertisements
Similar presentations
Identification of rheumatoid arthritis-associated PADI4, SLC22A4/A5, FCRL3 & PTPN22 International Symposium on Inflammatory Diseases of Barrier Organs.
Advertisements

Incomplete Dominance and Codominance
Figure 3 The induction of anti-DNA antibodies by bacterial DNA
Figure 1 Lymphocytes during the disease
Figure 3 Example of how a noncoding regulatory rheumatoid
Figure 3 Connexins in cartilage
Figure 1 Historical evolution of the clinical classification and
Figure 2 A timeline summarizing the development of diagnostic tools in rheumatology Figure 2 | A timeline summarizing the development of diagnostic tools.
Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 Enthesitis versus synovitis
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 Structure of TNF antagonists
Figure 1 Induction of immune tolerance
Figure 4 Simplified T cell and antigen presenting
Figure 3 Proposed mechanisms underlying the links
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 4 C-Terminal protein citrullination catalysed
Figure 1 Metabolic profiling as a tool for studying rheumatic diseases
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 4 Antinuclear antibodies and disease activity in SLE
Figure 3 Transcriptome studies performed in the target
Clinical summary of ACPA literature in early and established rheumatoid arthritis. Clinical summary of ACPA literature in early and established rheumatoid.
Figure 2 Shared genetic loci in systemic autoimmune diseases
Figure 7 Defects in apoptosis
Figure 1 Location of HLA variants known to be associated
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Strategies to achieve therapeutic inhibition of IL-1
Figure 3 Hypothetical mechanisms of smoking-associated
Figure 4 Post-test probability as a function of pre-test
Figure 2 Overlap of associated loci among five rheumatic diseases
Nat. Rev. Rheumatol. doi: /nrrheum
Work arrangements, productivity, and self-confidence at work as affected by RA. a For example: Stopped working altogether, moved from full-time to part-time.
Figure 3 Statistical approaches for the analysis of metabolomic data
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 5 The role of Ly6Chi and Ly6Clo monocytes
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Effect of sialylated glycoforms on IgG activity
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Conversion to ACPA and RF seronegative status in patients with early RA treated with abatacept+MTX compared with MTX alone. Conversion to ACPA and RF seronegative.
Figure 1 Biospecimen handling pipeline
Figure 1 The current model of the pathogenesis of SLE
Figure 6 Metabolism of pterins
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 Principles for the diagnosis and management of osteoarthritis
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Genetic Distinctions in Patients With Primary Sclerosing Cholangitis: Immunoglobulin G4 Elevations and HLA Risk  Evaggelia Liaskou, Gideon M. Hirschfield 
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Chronic inflammation and DNA damage in people with SLE
Figure 3 Nuclear-penetrating autoantibodies and synthetic lethality
Figure 4 Intracellular distribution and
Figure 2 Cellular contributions to the development of SLE
Fig. 1 Anti-LtxA antibody concentrations in various patient groups.
Figure 1 Patterns of joint and organ involvement in rheumatic disease
Figure 4 Role of chemokines in dendritic cell migration
Schematic illustration of the concepts in the pathogenesis of rheumatoid arthritis associated-interstitial lung disease (RA-ILD). Schematic illustration.
Figure 1 Kernel density plots
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 The role of macrophages in RA
Gene-Gene and Gene-Environment Interactions Involving HLA-DRB1, PTPN22, and Smoking in Two Subsets of Rheumatoid Arthritis  Henrik Källberg, Leonid Padyukov,
Nat. Rev. Rheumatol. doi: /nrrheum
ACPA and RF titres in patients with early RA treated with abatacept+MTX compared with MTX alone. ACPA and RF titres in patients with early RA treated with.
Fig. 1 Anti-LtxA antibody concentrations in various patient groups.
Presentation transcript:

Figure 2 Interaction effects between heterozygous HLA‑DRB1 alleles on anti-citrullinated protein autoantibody-positive rheumatoid arthritis risk Figure 2 | Interaction effects between heterozygous HLA-DRB1 alleles on anti-citrullinated protein autoantibody-positive rheumatoid arthritis risk. Non-log-additive interaction effects between heterozygous HLA-DRB1 alleles generally increase the risk of anti-citrullinated protein autoantibody (ACPA)-positive rheumatoid arthritis (RA). Homozygotes for HLA-DRB1 allele A (red) or B (blue) express homogenous HLA-DR proteins A or B, by which autoantigens are presented in an allele-specific manner. Individuals who have heterozygous HLA-DRB1 alleles might have larger autoantigen repertoires than homozygotes, and the existence of two different alleles might provide additional codominant risk effects because of the likelihood of presenting various kinds of autoantigens. The codominance effect of two alleles is statistically well explained by the interaction term ORA*B. AgA, antigens presented by HLA-DR molecule A; AgB, antigens presented by HLA-DR molecule B. Kim, K. et al. (2016) Update on the genetic architecture of rheumatoid arthritis Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2016.176